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Highlights
 Wearable trackers have acceptable accuracy, especially for measuring step counts, 
moderate to vigorous physical activityMVPA, ECG and HRheart rate, and for 
electrocardiography, but not for measuring respiratory rate (RR).
 Most older adults have reported ease of use and also demonstrated high-level adherence 
over daily long-term use.
 Methodological designs for data collection were have been heterogeneous and currently 
there are no standardised methods for quantifying data from wearable devices in older 
adults. As such f
 Frameworks and / or guidelines, are needed to support the ongoing use of wearable trackers 
to capture the physical activity of older adults.
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Abstract
Background: Wearable trackers as research or clinical tools are increasingly used to support the care 
of older adults, due to their practicality in self-monitoring and potential to promote healthy lifestyle 
behaviours. However, there is limited understanding of appropriate data collection methods and 
analysis for  methods in different contexts still exists. 
Aim: To summarise evidence on wearable data generation and management in older adults, focusing 
on physical activity (PA), electrocardiogram (ECG), and vital signs monitoring. In addition to examine 
the accuracy and utility of incorporating wearable trackers into the care of older people.  
Methods: A systematic search of CINAHL, MEDLINE, PubMed and a manual search were conducted. 
Twenty studies targeting on the use of wearable trackers use by in older adults met the inclusion 
criteria.
Results: Methodological designs for data collection and analysis were heterogeneous, with diverse 
definitions of wear and no-wear time, the number and type of valid days, and proprietary 
algorithms. Wearable trackers had adequate accuracy for measuring step counts, moderate to 
vigorous physical activity (MVPA), ECG and heart rate (HR), but not for respiratory rate. Participants 
reported ease of use and had high-level adherence over daily long-term use. Moreover, wearable 
trackers encouraged users to increase their daily PA level of physical activity and decrease waist 





























































Conclusion: Wearable trackers are multi-dimensional technologies offering a viable and promising 
approach for sustained and scaled monitoring of older people’s health. Frameworks and/or 
guidelines, including standards for the design, data management and application of use specifically 
for older adults, is are required to enhance validity and reliability. 
Keywords
older, physical activity, wearable, sensor, monitor, tracker
1. Introduction 
Aging populations with their high prevalence of chronic diseases have a significant impact on the 
healthcare system of any country. Fortunately, extraordinary advances in wearable tracker 
technology promote the potential to meet the demands of the healthcare system and facilitate the 
care of older adults. Notably, a wide array of commercial wearable trackers have recently appeared 
on the market. These trackers are inexpensive and are equipped with advanced functionality that 
utilises proprietary sensor technologies and data processing formulas to offer users a real-time 
assessment of their physiological, physical, psychological, and behavioural data [1, 2]. This includes 
data on heart rate (HR), blood pressure (BP), respiration rate (RR), electrocardiogram (ECG), and 
physical activity (PA) levels [1, 2]. Therefore, wearable trackers offer a practical alternative for 
everyday monitoring of PA, ECG and vital signs [2].  
Although older adults perceive wearable trackers as beneficial and acceptable [3], the fast advances 





























































standards of practice for monitoring calibration and validation and field application, such as for the 
objective monitoring of PA [4]. Specifically, how to collect, calibrate, process, and use data from 
wearable trackers continues to be one of the critical challenges when using these devices [4]. It is 
also important to note that accelerometry assumptions for the selection of cut-points and data 
analysis are not standardised across research protocols [5, 6]. Most research guiding accelerometry 
data analysis methods is derived from studies that involved children and young adults [5, 7, 8], and 
there is limited research on accelerometry data in older adults6. Consequently, the primary aim of 
this paper is to present a systematic review of wearable data generation and management in older 
adults focusing on PA, ECG and vital signs monitoring (i.e., HR, BP, and RR). The secondary aim is to 
examine accuracy and the utility of incorporating wearable trackers into the care of older adults.  
2. Methods
Both an electronic database search of CINAHL, MEDLINE, PubMed and a manual search were 
performed to identify the relevant articles. The search included the following terms: (1) ‘sensor’ or 
‘monitor’ or ‘device or ‘tracker’, and (2) ‘wearable’. We limited our search to adults aged 65 years 
and older using relevant Medical Subject Headings. We included studies which met the following 
criteria: (1) published in English and targeted older population (i.e.,  65 years old), (2) specifically 
investigated health-related wearable trackers; (3) study outcome focused on PA (i.e., active minutes 
and step counts), ECG, and vital signs monitoring. We excluded studies that primarily involved 
traditional pedometers or research grade trackers such as the ActiGraph accelerometer. We also 
excluded studies that mainly examined ‘gait’ and ‘falls’ because a recent published review9 has 






























































Using the above keywords, the initial search retrieved 485 studies of which 20 were eligible for full 
review (Figure 1). Any disagreements about inclusion were resolved through conversation between 
two team members (MA and RG). The Critical Appraisal Skills Programme (Cohort Study) Checklist 
was used to assess the quality of the reviewed studies. On assessment, although five of the studies 
met a minimum 80% of the evaluation criteria, the majority of the included studies were of poor to 
moderate quality. The findings of the reviewed studies were extracted manually and summarised in 
tables.
3. Results 
3.1 Overview of the wearable trackers included in the reviewed studies
Twelve different wearable trackers and 20 studies were included in this review (Table 1). Trackers 
include: ADAMO Care Watch, Fitbit Charge HR, Fitbit Flex, Fitbit One, Fitbit Zip, HealthPatch MD, 
iRhythmZio, Jawbone UP, MagIC, Misfit Shin, Nike+FuelBand, and Polar A300. The most commonly 
used wearable trackers across all reviewed studies were Fitbit One (n=7) and Fitbit Charge HR (n=4). 
It should be noted, there is a high turnover rate of wearable trackers available on the market so that 
one of the trackers reviewed, Jawbone UP, discontinued in 2011.   
3.2 Data acquisition in the reviewed studies 
The sample characteristics of the 20 included studies, wearable tracker name, data collection 
method, and analysis protocols are summarised in Table 2. The majority of the reviewed studies had 
PA as their focus (n=15), followed by ECG (n=3) and then vital signs (n=2).
The sample sizes ranged from eight to 2659 (total 3741 participants). The overall mean age was 69 





























































participants, females (42%). The diagnoses varied widely among the studies, but almost half the 
studies (n=8) included participants who had or were at high risk of cardiovascular disease. Twelve 
studies were conducted in a free-living environment, 6 studies were conducted in a controlled 
environment, and 2 studies utilised both controlled and free-living environments. The wearable 
trackers were placed on the wrist (n=12), waist (n=8), chest (n=4), ankle (n=2) and pocket (n=2). 
Data collection, and analysis protocols were heterogeneous.  The overall duration of the data 
collection ranged from two minutes to eight months. Among the studies conduction in a free-living 
environment, the tracker wear time was during all waking hours (i.e. valid day with ≥10 wear 
hours/day) in three studies, and for 24 hours in 11 studies. The definition of wear time varied among 
the reviewed studies. For instance, a cut-off threshold of 150 minutes [10] or 60 minutes [11] of 
continuous zero data from the wearable tracker was deemed as being non-wear data. Participants 
were required to wear the tracker for at least seven consecutive wearing days in over half of the 
included studies (11 of 20); at least five consecutive wearing days in one study; at least four 
consecutive wearing days including weekend days and weekdays in one study; with the remaining 
studies (7 of 20) including three consecutive wearing days or less. The algorithms and classifiers used 
for the feature computation varied among the reviewed studies. The majority of studies utilised 
proprietary algorithms that set its sampling interval at 60 seconds, but the shorter epochs (15 
seconds) were reported in one study. Similarly, almost all of the studies used proprietary algorithms 
(not known to the authors, as the formulas are proprietary to the company) to define the cut point 
of the measured outcomes; for example, minutes of moderate to vigorous physical activity (MVPA). 
Two studies utilised clinicians (e.g., cardiologists) to manually score and classify the data.   





























































Twelve [1,10,23,26-29,31-33,38-39] of the 20 reviewed studies targeted validity and/or reliability 
(Table 3). Overall, eight studies examined the validity and/or reliability of different wearable trackers 
in measuring step counts [10,26-29,32,33]. The outcomes of these studies supported the validity and 
reliability of the wearable trackers in tracking step counts but noted that walking at slow speeds and 
wrist-worn trackers may affect their accuracy. Two studies highlighted the capabilities of wearable 
trackers in accurately tracking active minutes of PA, especially MVPA [30,31]. Similarly, two studies 
showed wearable trackers had acceptable validity for measuring HR [38,39]. One study found that 
wearable trackers provide an accurate ECG reading [23]. However, one study warned against the use 
of wearable trackers for measuring respiratory rate as its accuracy was outside acceptable limits 
[38]. 
3.4 Data utility: Outcomes of the reviewed studies regarding the clinical benefits of wearable trackers 
and their acceptability
Eight of the 20 reviewed studies targeted the data utility of wearable trackers (Table 4). Four [24-
25,34,37] of the eight studies centred focused on the usefulness of wearable trackers as a measure 
of clinical outcomes, three studies [3,11,34] focused on the participants’ acceptance, adoption or 
abandonment of wearable trackers, one study [36] included both of the aforementioned aims, and 
one study examined the usefulness of wearable trackers as a motivational tool for PA behaviour 
change.
Regarding the clinical benefits, one study found a significant relationship between steps taken, 
length of stay, and dismissal disposition [37]. One study showed self-monitoring of PA using 
wearable trackers decreased waist circumference significantly [35], and two studies highlighted that 
wearable self-applied ECG patches facilitated AF diagnoses [24,25]. Moreover, one study [36] 





























































wearable tracker acceptability, three [3,11,35] studies found that participants reported the wearable 
trackers were easy to use and they also had high-level adherence over daily long-term use. However, 
one study [34] found that abandonment-related issues influencing daily long-term use of wearable 
trackers involved the collection of inaccurate data, time wasting, and wearing discomfort. 
4. Discussion  
Our results showed that overall, wearable trackers had adequate accuracy, especially for measuring 
step counts, MVPA, ECG and HR, but not for measuring RR. Moreover, most participants reported 
ease of use and also demonstrated high-level adherence over daily long-term use. Some 
participants, however, found the wearable trackers very difficult to use, and it is therefore important 
to consider the usability, comfort and feasibility of the trackers for older participants. Importantly, 
wearable trackers have become standard objective methods for assessing health outcomes such as 
PA. They have also demonstrated the usefulness of wearable technology for encouraging users to 
increase their daily PA level and to decrease their waist circumference, facilitating AF diagnoses and 
predicting hospital length of stay [24, 35, 37]. Therefore, wearable trackers may be promising for use 
among this cohort to help in diagnosing, monitoring and encouraging sustained changes in healthy 
behaviours such as PA. 
Importantly, our findings highlighted that methodological designs for data collection were 
heterogeneous and that there is no standardised method for quantifying data from wearable 
devices in older adults. Given the lack of a universally accepted definition [12, 13] for data collection 
and analysis of wearable trackers, future research is needed to produce specific assumptions for this 
work that is most applicable for older people, particularly accounting for their physical capacity. It is 
vital to standardise tracker placement and the number and type of valid days needed to achieve 





























































most common practice for PA measurement is a minimum of four days of valid data for analysis, 
including weekend days [14].  It is also critical to standardise the definitions of wear time and no-
wear time. For instance, the criteria for no-wear time most commonly applied is removal of the 
tracker for 60 minutes or more of continuous zeros, with allowance of 1-2 minutes [15], but 90 
minutes has been proposed for older people with limited mobility [16]. 
Of note, almost all the review studies relied on tracker proprietary algorithms, which set the 
sampling interval at different short or long epochs. Thus, a standardised algorithm or cut points to 
define an outcome (e.g. MVPA) are critical to support the tracker validity and reliability. A 
considerable amount of time and effort has been invested by researchers and manufacturers to 
make sure the algorithms in wearable trackers accurately measure clinical outcomes such as PA 
level. However, this pursuit presents numerous issues and challenges for stakeholders; namely, 
clinicians, researchers, tracker manufactures and patients [1]. Algorithms to aggregate raw tracker 
data into operational variables are regularly modified and frequently not available [17]. For instance, 
the Fitbit manufacturer recently modified the algorithm used to count active minutes without 
notification. All stakeholders are therefore eager to ensure tracker accuracy facilitates the precise 
monitoring of PA and other important health outcomes. Hence, wearable tracker manufacturers 
need to ensure the algorithm delivers high-level accuracy equal to research-grade accelerometers 
(e.g. Actigraph) and to inform stakeholders when modifications to the algorithms occur to uphold 
their trust. 
There are difficulties in ensuring the literature remains up to date on current models due to the 
frequency of new releases of wearable trackers17. Moreover, consideration must be given to the 
high turnover rate of wearable trackers in the market and that some trackers are no longer 
produced (e.g. Jawbone). The wide range of tracker features (e.g. step counts, active minutes and 





























































measuring health outcomes such as all dimensions of PA [17]. Uncertainties around the ownership 
of data and therefore accessibility to the data for research purposes also presents challenges to 
review boards in institutions as essentially it is data collection from third parties [1, 18]. In addition, 
there are issues regarding data structure and quality due to tracker manufacturers not sharing the 
data or their data collection methods with researchers [1, 18, 19]. Lastly, given we live in the digital 
personal health era, issues may emerge over data privacy [1, 18]. Hence, future research is needed 
to generate studies on privacy policies of wearable trackers and also to review federal and state 
legislation related to data protection.  
Notably, the acceptable level of inaccuracy varied and often was not clearly defined. Indeed, even in 
the literature there is no widely agreed definition of acceptable degree of error for PA wearable 
trackers. Acceptable measurement error for PA under controlled conditions or for research purposes 
is suggested to be within ±3% [20, 21], and under free-living conditions is within ±10% [20, 21]. 
Other literature advises that errors of less than 20% have acceptable validity for clinical purposes 
[22]. Depending upon the work being studied and the purposes of the validation study, it is 
important for future studies with elderly participants to standardise the analysis methods in order to 
guide validity interpretation for wearable trackers and to highlight the different validity criteria 
between the tested and criterion measures for clinical purposes compared to research purposes. 
Finally, it is worth noting that gender differences are likely, yet seldom examined. Only one study 
[30] analysed data separately by gender using Fitbit-Flex noted that male participants recorded 
significantly more steps and higher MVPA minutes than their female counterparts. 
Several limitations need to be acknowledged. We searched only a limited number of databases and 
reviewed articles published in English only so some studies may have been missed. Also, there is 
insufficient reporting for the accelerometry assumptions in several of the reviewed studies, creating 





























































5. Implications for practice and future research
The findings of this review have a number of important implications:
1. Wearable trackers are generally valid, reliable and/or feasible when tracking step counts, 
MVPA, ECG and HR in aging populations. Thus, trackers may be ideal to help in diagnosing, 
measuring, monitoring and/or motivating in this population cohort.  
2. There needs to be a framework and/or guidelines and a standardised method for the 
collection and analysis of wearable tracker data specifically for older people’s physical 
capacity.
3. Manufacturers of trackers must ensure the tracker algorithm delivers a high level of 
accuracy similar to a research-grade accelerometer.
4. Although there is extensive validity and reliability research available, there are no studies 
examining the responsiveness of wearable trackers. Thus, further research is needed to 
develop evidence-based responsiveness. 
6. Conclusion 
A definitive recommendation for a wearable tracker or method of data collection and analysis could 
not be made due to lack of strong evidence as the majority of primary studies used proprietary 
algorithms and there is no way to access the primary data. However, wearable trackers are generally 
valid, affordable and useful for monitoring a number of clinical outcomes such as PA, ECG and vital 
signs in real-time, and for accounting for day-to-day variations. This encourages more accurate and 
personalised clinical intervention for older people. Wearable trackers are promising tools for 





























































trackers are impacted by a number of factors including fast-paced technological developments, 
frequent updates to algorithms by manufacturers, and an absence of a consensus protocol for data 
collection and analysis. Future research is encouraged to develop guidelines and standards for the 
design and application of wearable technology in aging populations.
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Records identified through 
database and hand searches
n= 485
Records excluded after title and 
abstract screening
n= 445





Full-text articles excluded 
n= 20 
Table 1: Wearable trackers included in the review
Tracker Released date What is measured Software Battery life
ADAMO Care Watch 2010 Steps, distance,
calories, active
minutes




Fitbit Charge HR Jan 2015 Steps, distance,
calories, active
minutes, sleep, HR










Fitbit One Sep 2012 Steps, distance,
calories, active
minutes, sleep




Fitbit Zip May 2013 Steps, distance,
calories, active
minutes, sleep




HealthPatch MD Jan 2015 Single-Lead ECG, HR, 
HR Variability, vital 





iRhythmZioXT Jan 2011 Single-Lead ECG, HR Online-feedback, also 
phone apps
14 days
Jawbone UP Nov 2011







MagIC: a textile-based 
wearable system











Nike+ FuelBand Nov 2013 Steps, calories Online-feedback, also 
phone apps
4 days
Polar A300 Feb 2015 Steps, distance,
calories, active
minutes, sleep, HR






















Data cleaning Cut points 
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al.23
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7 days; direct 
observation on 
days 1 and 7
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for free-living 
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Steps Controlled Wear during 
walking for 
a distance of 
15m with 8 
different 
walking trials
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testing session  










Fitbit Flex Wrist Steps & 
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data in all 
patients.
• Light- activity = 
1.1 to 2.9 METs
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activity = 3.0 to 
5.9 METs
 • Vigorous- 
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Over 90 days, 
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for 24h a day
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Wrist HR Controlled Wear at all 
times


























CR = cardiac rehabilitation; ECG = Electrocardiography; PA = physical activity; AF = atrial fibrillation; LOS = length of stay; ICU = intensive care unit; METs = metabolic equivalent tasks; NR = not 
reported; h = hours; m = minutes; s = seconds; Hz = hertz 
Table 3: Data accuracy: Outcomes of the reviewed studies in terms of reliability and/or validity
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severe clinical 
conditions, 
recording was 30m 
while subjects at 
rest in bed in the 
hospital cardiac unit




















In static condition 










With remaining 20 
patients, ECGs were 




protocol: at rest 







(15m) and during a 
6MWT.
movement MagIC 
provides an ECG 









during a 2MWT and 
then during free-
living activities 
























a distance of 15 








































attainment of PA 
guideline 
recommendation





















SWA  for 
assessment
of PA time, step 











Steps StepWatch StepWatch, Fitbit 
One, and 
Jawbone UP 




































Fitbit Zip Steps Shimmer3 A speed of 3.6 





using Zip.  
Inaccuracies 
directly related to 
slow speeds, and 
thus for patients 
with cardiac
disease who walk 

















Compared to the 
ActiGraph GT3X+, 
the waist-worn 









MWT = minute walk test; PA = physical activity; HR = heart rate; LOS = length of stay; ECG = electrocardiography; AF = atrial 
fibrillation; ICU = intensive care unit; IHD = ischemic heart disease; h = hours; m = minutes; Sensewear = SWA
  
















and activity tracker 
over 90 days in a 




Using continuous-time activity trackers with 
HR monitors can be effective in a 
telemonitoring application, as patients had 
a high level of adherence (90% median 
usage) and low attrition








usability issues were 
assessed and 




Unified Theory of 






Initial attitudes were positive, but after 
using the tracker for two weeks, attitudes 
were mixed. 3 participants indicated they 
would continue using the tracker; whereas, 
5 would abandon the tracker and described 
several issues including inaccurate data 







To assess short and 
long-term 
experiences of Fitbit 




in the technology 
acceptance model.
Fitbit One 91% agreed or strongly agreed that the 
tracker was easy to use, useful & 
acceptable both 10 weeks and 8
months after enrolling in the study. Ratings 
slightly dropped between these time points 
in all survey domains: ease-of-use, 










To evaluate the 
feasibility and utility 
of activity tracker use 




efficacy, and health 
outcomes
Nike Fuel Participants found activity trackers easy to 
use, experienced a significant decrease in 
waist circumference. However no change in 









To evaluate the 
effect of 
accelerometer-based 





Fitbit One Exercise training combined with 
accelerometer-based feedback effectively 











Examine an activity 
tracker to measure 
PA  during hospital 
recovery after cardiac 
surgery.
Fitbit One There was a significant relationship 
between the number of steps taken in the 
early recovery










To determine effect 
of self-applied 
wearable ECG patch
in detecting AF and 
the clinical 
consequences 
iRhythmZio Among individuals at increased risk for AF, 














detect silent AF in 
asymptomatic in 
patients with known 
risk factors
iRhythmZio Tracker is feasible, with AF detected in 1 in 
20 subjects with up to 2 weeks of 
monitoring.
Also detected sustained atrial tachycardia 
and AF in 1 in 9 subjects
PA = physical activity; HR = heart rate; LOS = length of stay; ECG = electrocardiography; 
AF = atrial fibrillation; ICU = intensive care unit; IHD = ischemic heart disease  
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